Functional modules with disease discrimination abilities for various cancers

Science China Life Sciences

Volumn 54, Issue 2, 2011, Pages 189-193

  Yao, Chen ^a   Zhang, Min ^b   Zou, Jin Feng ^a   Li, Hong Dong ^a   Wang, Dong ^a   Zhu, Jing ^a   Guo, Zheng ^a,b  

^a UNIVERSITY OF ELECTRONIC SCIENCE AND TECHNOLOGY OF CHINA   (China)

^b HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79951570472     PISSN: 16747305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11427-010-4129-7     Document Type: Article

References (45)

1. Tusher V G, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA, 2001, 98: 5116-5121.
2. Jeffery I B, Higgins D G, Culhane A C. Comparison and evaluation of methods for generating differentially expressed gene lists from microarray data. BMC Bioinformatics, 2006, 7: 359.
3. Chen J J, Wang S J, Tsai C A, et al. Selection of differentially expressed genes in microarray data analysis. Pharmacogenomics J, 2006.
4. Cui X, Churchill G A. Statistical tests for differential expression in cDNA microarray experiments. Genome Biol, 2003, 4: 210.
5. Pavlidis P, Li Q, Noble W S. The effect of replication on gene expression microarray experiments. Bioinformatics, 2003, 19: 1620-1627.
6. Zhang M, Yao C, Guo Z, et al. Apparently low reproducibility of true differential expression discoveries in microarray studies. Bioinformatics, 2008, 24: 2057-2063.
7. Guo L, Lobenhofer E K, Wang C, et al. Rat toxicogenomic study reveals analytical consistency across microarray platforms. Nat Biotechnol, 2006, 24: 1162-1169.
8. Shi L, Reid L H, Jones W D, et al. The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. Nat Biotechnol, 2006, 24: 1151-1161.
9. Allison D B, Cui X, Page G P, et al. Microarray data analysis: from disarray to consolidation and consensus. Nat Rev Genet, 2006, 7: 55-65.
10. Wolfe C J, Kohane I S, Butte A J. Systematic survey reveals general applicability of "guilt-by-association" within gene coexpression networks. BMC Bioinformatics, 2005, 6: 227.
11. Breitling R, Armengaud P, Amtmann A, et al. Rank products: a simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experiments. FEBS Lett, 2004, 573: 83-92.
12. Yang D, Li Y, Xiao H, et al. Gaining confidence in biological interpretation of the microarray data: the functional consistence of the significant GO categories. Bioinformatics, 2008, 24: 265-271.
13. Khalil I G, Hill C. Systems biology for cancer. Curr Opin Oncol, 2005, 17: 44-48.
14. Morley M, Molony C M, Weber T M, et al. Genetic analysis of genome-wide variation in human gene expression. Nature, 2004, 430: 743-747.
15. Guo Z, Zhang T, Li X, et al. Towards precise classification of cancers based on robust gene functional expression profiles. BMC Bioinformatics, 2005, 6: 58.
16. Barrett T, Troup D B, Wilhite S E, et al. NCBI GEO: mining tens of millions of expression profiles-database and tools update. Nucleic Acids Res, 2007, 35: 760-765.
17. Garber M E, Troyanskaya O G, Schluens K, et al. Diversity of gene expression in adenocarcinoma of the lung. Proc Natl Acad Sci USA, 2001, 98: 13784-13789.
18. Bhattacharjee A, Richards W G, Staunton J, et al. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci USA, 2001, 98: 13790-13795.
19. Galamb O, Gyorffy B, Sipos F, et al. Inflammation, adenoma and cancer: objective classification of colon biopsy specimens with gene expression signature. Dis Markers, 2008, 25: 1-16.
20. Sabates-Bellver J, van der Flier L G, de Palo M, et al. Transcriptome profile of human colorectal adenomas. Mol Cancer Res, 2007, 5: 1263-1275.
21. Lapointe J, Li C, Higgins J P, et al. Gene expression profiling identifies clinically relevant subtypes of prostate cancer. Proc Natl Acad Sci USA, 2004, 101: 811-816.
22. Chen X, Leung S Y, Yuen S T, et al. Variation in gene expression patterns in human gastric cancers. Mol Biol Cell, 2003, 14: 3208-3215.
23. Chen X, Higgins J, Cheung S T, et al. Novel endothelial cell markers in hepatocellular carcinoma. Mod Pathol, 2004, 17: 1198-1210.
24. Rhodes D R, Chinnaiyan A M. Integrative analysis of the cancer transcriptome. Nat Genet, 2005, 37: 31-37.
25. Diehn M, Sherlock G, Binkley G, et al. SOURCE: a unified genomic resource of functional annotations, ontologies, and gene expression data. Nucleic Acids Res, 2003, 31: 219-223.
26. Ashburner M, Ball C A, Blake J A, et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet, 2000, 25: 25-29.
27. Dudoit S, Fridlyand J, Speed T. Comparison of discrimination methods for the classification of tumours using gene expression data. J Am Statisti Associ, 2002, 97: 77-87.
28. Zhang H, Yu C Y, Singer B. Cell and tumor classification using gene expression data: construction of forests. Proc Natl Acad Sci USA, 2003, 100: 4168-4172.
29. Alexa A, Rahnenfuhrer J, Lengauer T. Improved scoring of functional groups from gene expression data by decorrelating GO graph structure. Bioinformatics, 2006, 22: 1600-1607.
30. Falcon S, Gentleman R. Using GOstats to test gene lists for GO term association. Bioinformatics, 2007, 23: 257-258.
31. Hanahan D, Weinberg R A. The hallmarks of cancer. Cell, 2000, 100: 57-70.
32. Olivier S, Robe P, Bours V. Can NF-kappaB be a target for novel and efficient anti-cancer agents? Biochem Pharmacol, 2006, 72: 1054-1068.
33. Long Y M, Ye S, Rong J, et al. Nuclear factor kappa B: a marker of chemotherapy for human stage IV gastric carcinoma. World J Gastroenterol, 2008, 14: 4739-4744.
34. Hartwell L H, Kastan M B. Cell cycle control and cancer. Science, 1994, 266: 1821-1828.
35. Rosengren S, Henson P M, Worthen G S. Migration-associated volume changes in neutrophils facilitate the migratory process in vitro. Am J Physiol, 1994, 267: 1623-1632.
36. Saadoun S, Papadopoulos M C, Watanabe H, et al. Involvement of aquaporin-4 in astroglial cell migration and glial scar formation. J Cell Sci, 2005, 118: 5691-5698.
37. Larue L, Bellacosa A. Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3′ kinase/AKT pathways. Oncogene, 2005, 24: 7443-7454.
38. Jeanes A, Gottardi C J, Yap A S. Cadherins and cancer: how does cadherin dysfunction promote tumor progression? Oncogene, 2008, 27: 6920-6929.
39. Hynes R O. Metastatic potential: generic predisposition of the primary tumor or rare, metastatic variants-or both? Cell, 2003, 113: 821-823.
40. Hallahan A R, Pritchard J I, Chandraratna R A, et al. BMP-2 mediates retinoid-induced apoptosis in medulloblastoma cells through a paracrine effect. Nat Med, 2003, 9: 1033-1038.
41. Chuang H Y, Lee E, Liu Y T, et al. Network-based classification of breast cancer metastasis. Mol Syst Biol, 2007, 3: 140.
42. Taylor I W, Linding R, Warde-Farley D, et al. Dynamic modularity in protein interaction networks predicts breast cancer outcome. Nat Biotechnol, 2009, 27: 199-204.
43. Zhang M, Zhang L, Zou J, et al. Evaluating reproducibility of differential expression discoveries in microarray studies by considering correlated molecular changes. Bioinformatics, 2009, 25: 1662-1668.
44. Segal E, Friedman N, Koller D, et al. A module map showing conditional activity of expression modules in cancer. Nat Genet, 2004, 36: 1090-1098.
45. Campagne F, Skrabanek L. Mining expressed sequence tags identifies cancer markers of clinical interest. BMC Bioinformatics, 2006, 7: 481.